New perspectives on complement mediated immunotherapy

G Stasiłojć, A Österborg, AM Blom, M Okrój - Cancer Treatment Reviews, 2016 - Elsevier
Tumor-specific monoclonal antibodies (mAbs) offer several modes of tumor cell killing, from
direct cytotoxic activity to indirect mechanisms employing the host immune system …

New perspectives on complement mediated immunotherapy

G Stasiłojć, A Österborg… - Cancer Treatment …, 2016 - cancertreatmentreviews.com
Tumor-specific monoclonal antibodies (mAbs) offer several modes of tumor cell killing, from
direct cytotoxic activity to indirect mechanisms employing the host immune system …

New perspectives on complement mediated immunotherapy

G Stasiłojć, A Österborg, AM Blom, M Okrój - Cancer Treatment Reviews, 2016 - infona.pl
Tumor-specific monoclonal antibodies (mAbs) offer several modes of tumor cell killing, from
direct cytotoxic activity to indirect mechanisms employing the host immune system …

New perspectives on complement mediated immunotherapy

G Stasiłojć, A Österborg, AM Blom… - Cancer treatment …, 2016 - pubmed.ncbi.nlm.nih.gov
Tumor-specific monoclonal antibodies (mAbs) offer several modes of tumor cell killing, from
direct cytotoxic activity to indirect mechanisms employing the host immune system …

New perspectives on complement mediated immunotherapy

G Stasiłojć, A Österborg, AM Blom… - Cancer Treatment …, 2016 - portal.research.lu.se
Tumor-specific monoclonal antibodies (mAbs) offer several modes of tumor cell killing, from
direct cytotoxic activity to indirect mechanisms employing the host immune system …

[引用][C] New perspectives on complement mediated immunotherapy

G Stasiłojć, A Österborg, AM Blom, M Okrój - Cancer Treatment Reviews, 2016 - cir.nii.ac.jp
New perspectives on complement mediated immunotherapy | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

New perspectives on complement mediated immunotherapy

G Stasiłojć, A Österborg, AM Blom… - Cancer Treatment …, 2016 - lup.lub.lu.se
Tumor-specific monoclonal antibodies (mAbs) offer several modes of tumor cell killing, from
direct cytotoxic activity to indirect mechanisms employing the host immune system …

New perspectives on complement mediated immunotherapy.

G Stasiłojć, A Österborg, AM Blom… - Cancer Treatment …, 2016 - europepmc.org
Tumor-specific monoclonal antibodies (mAbs) offer several modes of tumor cell killing, from
direct cytotoxic activity to indirect mechanisms employing the host immune system …

[引用][C] New perspectives on complement mediated immunotherapy

G Stasiłojć, A Österborg… - Cancer Treatment …, 2016 - repozytorium.bg.ug.edu.pl